BASILEA LABORATORIES
Live / Applied — Fourth extension granted (statement of use) (as of 18 Aug 2025)
What this means for you
Not registered yet, but its 05 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97578739
- Mark type
- Stylized text
- Filed
- 05 Sept 2022
- Published for opposition
- 27 Jun 2023
- Attorney of record
- Evan A. Raynes
Goods and services
- Class 001 — Chemicals: Diagnostic preparations for clinical or medical laboratory use; Diagnostic reagents for clinical or medical laboratory use
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for the treatment or prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary preparations for the treatment of infections caused by bacteria, fungi, viruses and rheumatoid arthritis; Pharmaceutical and veterinary preparations for the treatment of diseases, disorders and conditions in the area of oncology
Owner
- Basilea Pharmaceutica AG, Basel, CH
- Basilea Pharmaceutica AG, Basel, CH
Prosecution history
- 16 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2025 — SOU EXTENSION 4 GRANTED
- 18 Aug 2025 — SOU EXTENSION 4 FILED
- 18 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — SOU EXTENSION 3 GRANTED
- 13 Feb 2025 — SOU EXTENSION 3 FILED
- 12 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Aug 2024 — SOU EXTENSION 2 GRANTED
- 14 Aug 2024 — SOU EXTENSION 2 FILED
- 13 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 17 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Feb 2024 — SOU EXTENSION 1 GRANTED